Evaluating risk factors, biomarkers and management of myocarditis following treatment with checkpoint inhibitors. A retrospective analysis.
Event:
ESC Congress 2022
Topic:
Epidemiology, Prognosis, Outcome
Session:
National registries for rare myocardial diseases
